DIGITAL CARDIAC CARE

DIGITAL CARDIAC CARE

Digital health solution to help patients track, diagnose, and treat hypertension and other cardiac diseases.

Careers:

Leadership:

Maayan Cohen

CEO, Founder

Ziv Meltzer

Co-founder

Location:

Menlo Park, CA

Since:

2022

Status:

Current

Stage:

Growth

Investments
Software
DIGITAL CARDIAC CARE

DIGITAL CARDIAC CARE

Software
DIGITAL CARDIAC CARE

DIGITAL CARDIAC CARE


Digital health solution to help patients track, diagnose, and treat hypertension and other cardiac diseases.



Careers:

Leadership:


Maayan Cohen

CEO, Founder

Ziv Meltzer

Co-founder

Location:

Menlo Park, CA


Since:

2022


Status:

Current


Stage:

Growth


scroll

Hello Heart is an engaging, well-designed product that has the potential to improve the lives of millions of Americans while changing the way in which large employers manage cardiac disease.

Hello Heart is the first dedicated digital health program that HR/benefits leaders at self-insured employers purchase to address hypertension and overall heart health among their employee populations. Patients engage with Hello Heart on an ongoing basis through its mobile application to track their blood pressure, BMI, medication, and other indicators of heart health.

Cardiac disease affects a shockingly high portion of the American population — 47% of adults suffer from hypertension, and cardiovascular conditions are the chronic disease driving the highest share of spend across the U.S. healthcare system. However, as disease-specific digital health solutions have exploded in terms of both new company innovation and employer adoption over the past 5-10 years, cardiology has been largely overlooked.

Unlike most digital options in the market that focus on addressing hypertension as a secondary element of other disease states such as diabetes, Hello Heart provides a dedicated solution focused exclusively on cardiac care. More importantly, existing solutions have not delivered the type of engaging, well designed product offering that can really move the needle on this crucially important problem.

There is substantive clinical research supporting Hello Heart’s ability to improve patient outcomes while reducing associated employer medical costs. According to a recent peer-reviewed study published in JAMA, 84% of Hello Heart users with baseline blood pressure over 140/90 saw sustained reductions in blood pressure for up to three years. Building off exceptional patient engagement and clinical results, we believe Hello Heart is well positioned to expand their product into a whole heart health solution.

The information noted above is representative as of the time noted/April 2022 and has not been updated.